Ragistomig Human Monoclonal Antibody
Ragistomigis a research-grade recombinant antibody targeting CD137. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
UniProt
Q07011, Q9NZQ7
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-scFv_L-kappa dimer
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1387104 Inquire
Recombinant Shigella boydii serotype 4 Probable replication endonuclease from prophage-like region (SBO_0752), partial
Sign In for Pricing
View Details 
OR1050359-01 100 mg
(R) -N- (2-Nitrophenyl) pyrrolidin-3-amine hydrochloride
Sign In for Pricing
View Details OR1050359-02 250 mg
(R) -N- (2-Nitrophenyl) pyrrolidin-3-amine hydrochloride
Sign In for Pricing
View Details